Specificity questions concerning the clone 33 anti-fas ligand antibody
Open Access
- 1 January 2000
- journal article
- editorial
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 7 (1) , 8-9
- https://doi.org/10.1038/sj.cdd.4400644
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Antibody mAb33 from transduction laboratories detects human CD95L in ELISA but not in immunoblots.Cell Death & Differentiation, 2000
- mAb 33 from Transduction Laboratories specifically binds to human CD95-LCell Death & Differentiation, 2000
- Functional Fas Ligand Expression in Thyrocytes from Patients with Graves’ DiseaseJournal of Clinical Endocrinology & Metabolism, 1999
- Differential T cell response in central and peripheral nerve injury: connection with immune privilegeThe FASEB Journal, 1999
- Lymphocyte apoptosis induced by Fas ligand- expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes.Journal of Clinical Investigation, 1998
- Constitutive Expression of FasL in ThyrocytesScience, 1998
- Fas (APO-1, CD95)-Mediated Apoptosis in Thyroid Cells Is Regulated by a Labile Protein Inhibitor*Endocrinology, 1997
- Differential Induction of Apoptosis by Fas–Fas Ligand Interactions in Human Monocytes and MacrophagesThe Journal of Experimental Medicine, 1997
- Fas Ligand-Induced Apoptosis as a Mechanism of Immune PrivilegeScience, 1995
- A role for CD95 ligand in preventing graft rejectionNature, 1995